Study Stopped
Poor recruitment
Oocyte Cryopreservation by Slow Freezing and Vitrification
Longitudinal Evaluation of Vitrification of Human Oocytes
1 other identifier
interventional
2
0 countries
N/A
Brief Summary
This study seeks to evaluate whether the vitrification technique, as compared to the more traditional slow-cooling technique, leads to higher rates of successful thawing, fertilization, implantation and delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jul 2009
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 8, 2010
CompletedFirst Posted
Study publicly available on registry
October 18, 2010
CompletedNovember 19, 2013
November 1, 2013
1 year
October 8, 2010
November 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oocytes survival after thaw
Whether each oocyte survives the thawing process
1 month
Secondary Outcomes (2)
Fertilization
1 month
Implantation
1 month
Study Arms (2)
Slow Freezing
EXPERIMENTALoocytes will be frozen by slow freeze/ rapid thaw
Vitrification
EXPERIMENTALoocytes will be frozen using rapid freezing/rapid thaw
Interventions
Eggs will be placed in a cryo-protected solution and frozen slowly in a programable freezer
Eggs will be placed in a high concentration of cryo-protectant and frozen very quickly by plunging in liquid nitrogen
Eligibility Criteria
You may qualify if:
- Age between 21 and 50 years, at the time of informed consent.
- Subjects must agree to undergo intracytoplasmic sperm injection (ICSI)
You may not qualify if:
- Presence of any medical condition that contraindicates ovarian stimulation, in vitro fertilization or pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Richard T Scott, MD, HCLD
RMA of NJ
- STUDY CHAIR
Kathleen Ferry, BS
RMA of NJ
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2010
First Posted
October 18, 2010
Study Start
July 1, 2009
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
November 19, 2013
Record last verified: 2013-11